Wcn24-1688 Self-Reported Quality of Life in Complement 3 Glomerulopathy Patients Delineated by CKD Stage: A Real-World, Multi-Country Survey

Complement 3 glomerulopathy (C3G) is a rare, chronic kidney disease (CKD), with an estimated worldwide incidence of 1-2 million people/year. C3G is associated with a high risk of disease progression and later stages are associated with worsening symptoms, but there are limited published data describing the health-related quality of life in patients with C3G. We aimed to evaluate the impact of CKD stage on the health-related quality of life in a multi-country study of C3G patients.